Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vertex Pharmaceuticals (NQ: VRTX )

350.15 -3.80 (-1.07%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Vertex Pharmaceuticals

< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Why Are Investors Ignoring Vertex's Good News?
Vertex announced promising trial data for its type 1 diabetes treatment candidate. 
Via The Motley Fool
If You Invested $5,000 in Vertex Pharmaceuticals In 2016, This Is How Much You Would Have Today
Your returns would have been great until recently. 
Via The Motley Fool
Vertex Unveils First Patient Results On Potential Diabetes Treatment
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) has announced Day 90 data for the first patient from the Phase 1/2 trial of VX-880 for type 1 diabetes (T1D).... 
Via Benzinga
3 No-Brainer Biotech Stocks to Buy Right Now
Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run. 
Via The Motley Fool
Crispr: A Fallen Angel In Gene Editing
As with most promising biotech companies, investors bid their prices up for CRSP based on its potential for early profits. When the payoff didn't occur on schedule, investors bailed out. Once it... 
Via Talk Markets
2 Beaten-Down Growth Stocks to Buy Hand Over Fist
For those focused on the long game, the recent poor stock performances of Vertex Pharmaceuticals and Veeva Systems may present buying opportunities. 
Via The Motley Fool
3 Winning Biotech Stocks to Buy Hand Over Fist
Here are the top biotech picks from three Motley Fool contributors. 
Via The Motley Fool
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc... 
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... 
Via Benzinga
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... 
Via Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (... 
Via Benzinga
September Sell-Off Alert: Buy Vertex Pharmaceuticals on the Dip
Shares of this highly successful biotech stock are trading at an all-time low earnings multiple. 
Via The Motley Fool
Exposures COVID-19
5 Stocks to Buy in the September Sell-Off
This eclectic mix has something for everyone. 
Via The Motley Fool
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 22) Acceleron Pharma Inc. (... 
Via Benzinga
Exposures COVID-19
3 Crash-Ready Stocks to Buy in September
History says this month can be scary. These stocks can get you through it. 
Via The Motley Fool
2 Top Biotech Stocks to Buy Right Now
Both have underperformed the market recently. And both are primed for a comeback. 
Via The Motley Fool
Cramer Gives His Opinion On Service Corporation, Vertex And More
On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp (NASDAQ: INSG) acts. He is beginning to believe it deserves to... 
Via Benzinga
Expert Ratings For Vertex Pharmaceuticals
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst ra... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE: 
Via Benzinga
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
Stocks of biotech companies fighting COVID-19 have been great investments over the last two years. What stocks might zoom higher when the pandemic is over? 
Via The Motley Fool
Exposures COVID-19
Where Vertex Pharmaceuticals Stands With Analysts
Vertex Pharmaceuticals (NASDAQ:VRTX) has observed the following analyst rat... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021
Upgrades BMO Capital upgraded the previous rating for BRP Inc (NASDAQ: 
Via Benzinga
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Vertex plans to work more closely on CRISPR gene editing with a small privately-held biotech. 
Via The Motley Fool
2 of the Best Stocks to Buy Right Now with Just $500
These top stocks are no-brainer buys for your portfolio this month. 
Via The Motley Fool
Moderna And DexCom Lead The Nasdaq-100
U.S. indices had a mixed day of trading Wednesday as investors weigh rising COVID-19 Delta variant cases nationwide. The Invesco QQQ Trust Series 1 (NASDAQ: QQQ) gained 0.17% to... 
Via Benzinga
Exposures COVID-19
The 3 Best Biotech Stocks to Buy Right Now
Let your portfolio reflect your personality. 
Via The Motley Fool
Where Vertex Pharmaceuticals Stands With Analysts
Over the past 3 months, 16 analysts have published their opinion on Vertex Pharmaceuticals (NASDAQ: 
Via Benzinga
3 Cathie Wood Stocks to Buy and Hold for Decades
If you own these companies, the hardest thing to do is sit back and forget about them -- and possibly the best. 
Via The Motley Fool
Vertex Inks Potential $1.2B Gene-Editing Pact With Arbor Biotechnologies
Vertex Pharmaceuticals Inc (NASDAQ: VRTX) and Arbor Biotechnologies have announced a new collaboration to develop ex vivo engineered cell therapies. The new... 
Via Benzinga
< Previous 1 2
...
27 28 29 30 31 32 33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.